List of insiders holdings for NewAmsterdam Pharma Co N.V.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | ForGrowth NAP B.V. Forbion Capital Fund IV Cooperatief U.A. Forbion IV Management B.V. Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner | 2025-09-30 16:47:41 | 9,316,914 0 | 9,316,914 | Form 13D |
| 2 | Topper James N Director | 2025-09-17 17:22:34 | 0 6,829,524 | 6,829,524 | Form 4 |
| 3 | Bain Capital Life Sciences Investors LLC BCLS Fund III Investments LP Bain Capital Life Sciences III General Partner LLC Bain Capital Life Sciences Fund III L.P. BCLS Fund III Investments GP LLC BCLS II Investco LP BCLS II Investco (GP) LLC Bain Capital Life Sciences Fund II L.P. Bain Capital Life Sciences Investors II LLC BCIP Life Sciences Associates LP 10% Owner | 2025-12-04 16:30:05 | 5,376,356 0 | 5,376,356 | Form 13D |
| 4 | Somaiya Mayur Ian Chief Financial Officer | 2026-01-22 17:24:59 | 1,423,794 0 | 1,423,794 | Form 4 |
| 5 | Davidson Michael H. Chief Executive Officer | 2026-01-09 19:34:21 | 823,859 0 | 823,859 | Form 4 |
| 6 | Kling Douglas F Chief Operating Officer | 2025-07-17 17:19:01 | 420,447 0 | 420,447 | Form 4 |
| 7 | Marino Michael F III See Remarks | 2025-06-03 17:02:34 | 370,000 0 | 370,000 | Form 4 |
| 8 | Kastelein Johannes Jacob Pieter Chief Scientific Officer | 2026-01-07 18:31:26 | 213,981 0 | 213,981 | Form 4 |
| 9 | Kooij Louise Frederika Chief Accounting Officer | 2026-01-07 18:27:55 | 77,853 0 | 77,853 | Form 4 |
| 10 | JONES WILLIAM A JR Chief Commercial Officer | 2025-01-07 17:12:26 | 43,000 0 | 43,000 | Form 4 |
| 11 | Audet Juliette Berangere See Remarks | 2025-05-02 16:56:15 | 30,000 0 | 30,000 | Form 4 |
| 12 | Gulfo Adele M. Director | 2026-01-09 19:34:36 | 29,560 0 | 29,560 | Form 4 |
| 13 | LANGE LOUIS G Director | 2026-01-09 19:33:10 | 25,660 0 | 25,660 | Form 4 |
| 14 | McKenna Mark C. Director | 2026-01-09 19:33:22 | 25,660 0 | 25,660 | Form 4 |
| 15 | Smither John W Director | 2026-01-09 19:33:38 | 25,660 0 | 25,660 | Form 4 |
| 16 | Lewis William Director | 2026-01-09 19:34:07 | 25,660 0 | 25,660 | Form 4 |
| 17 | van der Kamp Hilde Johanna Director | 2026-01-09 19:34:59 | 25,660 0 | 25,660 | Form 4 |
| 18 | Slootweg Hugo Alexander Director | 2023-12-29 16:30:14 | 0 0 | 0 | Form 3 |
| 19 | Joustra Wouter Director | 2024-07-19 16:30:04 | 0 0 | 0 | Form 3 |
| 20 | Downing Nicholas Director | 2023-12-29 17:04:20 | 0 0 | 0 | Form 3 |